Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-20 | Stefan Galluppi Consists of 1,150,000 shares held by American Nutra Tech, LLC, a company that Mr. Galluppi has sole voting and dispositive power. |
| 2019-12-16 | Stefan Galluppi 3,654,867 shares beneficially owned No specific role or committees mentioned in the filing. |
| 2020-12-07 | Stefan Galluppi Chief Operating Officer, Chief Technology Officer and Director 2019 111,000 - 450,000 - - - - 561,000 Mr. Galluppi was appointed as a member of the Board effective June 24, 2017. |
| 2021-05-12 | Stefan Galluppi – Chief Technology Officer and Director Stefan Galluppi was the Chief Executive Officer of Immudyne PR and the Chief Operating Officer of Immudyne. Stefan Galluppi is the Chief Executive Officer of Immudyne PR and the Chief Operating Officer of Immudyne. Mr. Galluppi resigned as a Director of Immudyne, Inc. in February 2018 upon the sale of the legacy beta glucan business but was re-appointed after the resignation of Mr. Aldridge on May 31, 2018. Mr. Galluppi combines over 10 years of experience in building technology platforms for direct to consumer marketing campaigns. Previously, he served as the CTO of Runaway Products, a DRTV driven marketing firm with a core focus on building and optimizing systems to scale campaigns for maximum efficiency and profitability. |
| 2022-04-29 | Stefan Galluppi – Chief Innovation & Marketing Officer and Director\nStefan Galluppi has served as the Chief Innovation & Marketing Officer of the Company since December 2020, and prior to that, as Chief Technology Officer of the Company from 2016 to December 2020. Mr. Galluppi also served as Chief Operating Officer from March 2019 to November 2020. |
| 2023-04-28 | Stefan Galluppi – Chief Innovation Officer and Director Stefan Galluppi currently serves as Chief Innnovation Officer of the Company. Mr. Galluppi has served as the Chief Innovation & Marketing Officer of the Company since December 2020, and prior to that, as Chief Technology Officer of the Company from 2016 to December 2020. |
Data sourced from SEC filings. Last updated: 2026-02-03